Moolec Science SA Warrant

MLECW

Market cap $134K

GRAND CAYMAN, CAYMAN ISLANDS / ACCESS Newswire / November 28, 2025 / On November 24, 2025, Moolec Science SA ("Moolec" or the "Company") received a letter (the "Letter") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) because it has not yet filed its Annual Report on Form 20-F for the year ended June 30, 2025 (the "Form 20-F") with the Securities and Exchange Commission (the "SEC"). As the Company stated in the form 12b-25 filed with the SEC on October 31, 2025, it was unable to file the Form 20-F in a timely manner due to complexities that arose immediately after the closing of the business combination in mid-June 2025, two weeks prior to Moolec's fiscal year end of June 30.

Moolec Science SA (NASDAQ:MLEC ) Q4 2024 Earnings Conference Call October 2, 2024 8:30 AM ET Company Participants Gaston Paladini - Chief Executive Officer Jose Lopez Lecube - Chief Financial Officer Martin Salinas - Chief Technology Officer Amit Dhingra - Chief Science Officer Bill Zima - ICR Strategic Communications Conference Call Participants Scott Fortune - Roth Capital Operator Good morning and welcome to Moolec Science's fourth quarter and full fiscal year 2024 conference call. My name is Bill Zima of ICR Strategic Communications and Advisory.

Moolec Science SA (NASDAQ:MLEC ) Q3 2024 Earnings Conference Call May 30, 2024 8:30 AM ET Company Participants Gaston Paladini - CEO and Co-Founder Amit Dhingra - Chief Science Officer Jose Lopez Lecube - CFO Bruce William - Plant Scientist Conference Call Participants Thomas McGovern - Maxim Group Scott Fortune - Roth MKM Bruce William This morning, you will hear from Gaston Paladini, Chief Executive Officer and Co-Founder of Moolec Science, together with Jose Lopez Lecube, Chief Financial Officer and Amit Dhingra, Chief Science Officer. In today's call, we will be referring to a presentation that is available on the company's Investor Relations website.

Moolec Science (NASDAQ: MLEC ) stock is taking off on Monday after the company got approval from the Food and Drug Administration (FDA) for its plant-grown animal proteins. According to a press release from the company, this covers its genetically engineered soybean that accumulates animal proteins.

Moolec Science (NASDAQ: MLEC ) stock is getting a boost on Thursday despite a lack of news from the science-based food ingredient company. There are no new press releases or filings with the Securities and Exchange Commission (SEC) that explain why the stock is rising today.

Moolec Science SA (NASDAQ:MLEC ) Q1 2024 Earnings Conference Call December 14, 2023 8:30 AM ET Company Participants Michael Bowen - ICR's, Strategic Communications and Advisory Gaston Paladini - CEO and Co-Founder Amit Dhingra - Chief Science Officer Jose Lopez Lecube - CFO Conference Call Participants Brian Wright - ROTH MKM Tom McGovern - Maxim Group Michael Bowen Good morning, and welcome to Moolec's Conference Call. My name is Michael Bowen, from ICR's, Strategic Communications and Advisory.